Pharma Exabyte 2015. Big data to unlock rare disease’s secret.

Big data is a new frontier for pharmaceutical companies. Its potential in research and development is enormous and it presents endless opportunities for every stage of a drug’s development. Pattern identification, predictive modelling, and more efficient, diversified-criteria-based clinical trials are only some of the possibilities big data opens to pharma companies. However, full integration of such capabilities requires operational and organizational transformations that most companies are still hesitant to implement. Furthermore, there is a very limited number of case studies available to learn from.
This event aims to do just that: bring experts who can offer you knowledge on what, how and when it can be done.
Wed, 27/05/2015 (All day) - Thu, 28/05/2015 (All day)
Berlin, Germany
Pharma Exabyte 2015_Draft Agenda.pdf668.48 KB